Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00261261 · ClinicalTrials.gov registry record · NA

Family-Centered Behavioral Preparation for Surgery

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT00261261: Completed NA study, sponsored by Yale University.

NCT00261261 is a NA study that has completed, run by Yale University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00261261, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

Children experience significant anxiety and distress during the preoperative period. Currently available interventions are ineffective and/or associated with significant disadvantages. These interventions exclusively target the child and do not attempt to reduce parental anxiety. Based on an integration of the literature in both the anesthesia and psychological milieus, we developed ADVANCE, a behaviorally oriented anxiety reduction program for children undergoing surgery that targets the family as a whole.

Interventions

  • DRUG Midazolam
  • BEHAVIORAL ADVANCE
  • PROCEDURE Parental presence

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2001-01
Est. Completion 2004-12
Phase NA
Yale University

1,492 total trials

What the finished NCT00261261 record still lists

NCT00261261 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.

NCT00261261 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00261261 about?

NCT00261261 is a clinical study titled "Family-Centered Behavioral Preparation for Surgery". Children experience significant anxiety and distress during the preoperative period. Currently available interventions are ineffective and/or associated with significant disadvantages. These interventions exclusively target the child and do not attempt to reduce parental anxiety. Based on an integra...

What is the current status of trial NCT00261261?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2001-01. Estimated completion is 2004-12.

What interventions are being tested in trial NCT00261261?

The interventions under investigation include: Midazolam (DRUG), ADVANCE (BEHAVIORAL), Parental presence (PROCEDURE).

Who is sponsoring clinical trial NCT00261261?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00261261's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00261261, the US trial registry maintained by the National Library of Medicine. NCT00261261 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.